CN Patent

CN112516097A — 一种苯磺酸左旋氨氯地平组合物

Assigned to Disha Pharmaceutical Group Co Ltd · Expires 2021-03-19 · 5y expired

What this patent protects

本发明涉及一种苯磺酸左旋氨氯地平片剂组合物，属于药物制剂技术领域。本发明的技术方案是：一种苯磺酸左旋氨氯地平组合物，含有苯磺酸左旋氨氯地平3.5%，牛磺酸2‑8%，填充剂70‑90%，丙二醇3‑9%，崩解剂5‑10%，润滑剂0.5‑2%。本发明提供了一种既能服药后能够在人体内快速释放，又能具有优良稳定性的苯磺酸左旋氨氯地平药物组合物。

USPTO Abstract

本发明涉及一种苯磺酸左旋氨氯地平片剂组合物，属于药物制剂技术领域。本发明的技术方案是：一种苯磺酸左旋氨氯地平组合物，含有苯磺酸左旋氨氯地平3.5%，牛磺酸2‑8%，填充剂70‑90%，丙二醇3‑9%，崩解剂5‑10%，润滑剂0.5‑2%。本发明提供了一种既能服药后能够在人体内快速释放，又能具有优良稳定性的苯磺酸左旋氨氯地平药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN112516097A
Jurisdiction
CN
Classification
—
Expires
2021-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Disha Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.